What is ENSITRELVIR used for?

ENSITRELVIR is being researched for the treatment of COVID-19, liver disease, and kidney disease.

Is ENSITRELVIR approved to treat COVID-19?

ENSITRELVIR is currently in Phase 3 clinical trials and is not yet a standard approved treatment.

Can ENSITRELVIR help with liver or kidney problems?

Studies are looking into whether ENSITRELVIR can be used for people with liver or kidney disease.

What stage of testing is ENSITRELVIR in?

ENSITRELVIR is currently in Phase 3 of clinical development.

Is ENSITRELVIR a small molecule drug?

Yes, ENSITRELVIR is classified as a small molecule.

Are there any known side effects of ENSITRELVIR?

Specific side effects for ENSITRELVIR are not listed in the current research summary provided.

ensitrelvir | CAS 2647530-73-0 | QMPBBNUOBOFBFS

Loading compound...

Small molecule

ENSITRELVIR is a small molecule drug currently in clinical development (Phase 3). It has been studied for its potential use in treating COVID-19, as well as for conditions related to liver and kidney disease.

Used for

COVID-19liver diseasekidney disease

Conditions

COVID-19Liver DiseasesKidney Diseases

Class

Small moleculeRespiratory systemHepatic systemRenal system

How to take

ENSITRELVIR is currently being studied in clinical trials and is not yet an approved treatment for these conditions in all settings. Information regarding specific dosing and administration is not yet available in the provided data.

Talk to your doctor

Questions to ask

·Is ENSITRELVIR appropriate for my stage of COVID-19?
·How might ENSITRELVIR affect my existing liver or kidney disease?
·When will ENSITRELVIR be available for general use?

Educational summary derived from FDA labeling, AI-assisted. Not medical advice — consult a healthcare professional. Updated 2026-04-26.

How to take

Talk to your doctor

Frequently asked questions (6)